Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109384794A reveals protic acid catalyzed route. High yield, green chemistry. Reliable supplier for scale-up.
Novel microwave-assisted method for fluoro-3,4-dihydroisocoumarin derivatives. High yield, mild conditions, cost-effective supply chain solutions for pharma intermediates.
Patent CN107266414A reveals copper-catalyzed C-H amination for aminomethyl thiophenes. This method offers significant supply chain and cost advantages for pharmaceutical intermediates manufacturing.
Novel Rh-catalyzed aminocarbonylation using dimethyl carbonate offers a green, high-yield route for acetamide production, ensuring cost-effective supply chain solutions.
Patent CN116640146A details a Pd-catalyzed one-pot synthesis. Offers high purity, scalable production, and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN114539198B details a novel Pd-catalyzed route for chroman amides. Offers cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN100389877C details a novel PEG-supported ruthenium catalyst enabling ambient pressure asymmetric hydrogenation, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel iodine-promoted synthesis of trifluoromethyl-triazoles via patent CN113105402B. A cost-effective, scalable route for high-purity pharmaceutical intermediates without heavy metals.
Patent CN114195711B details a novel Pd-catalyzed carbonylation route. Offers safer processing and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN117736120A reveals a metal-free synthesis route for β-fluoroalkyl-β-aminovinyl ketones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN119320392A details a green catalytic route for Rucaparib. This report analyzes cost reduction in API manufacturing and supply chain reliability for procurement teams.
Patent CN113896648B reveals nickel-catalyzed synthesis avoiding toxic CO gas. Delivers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN115215814A details a novel Rh-catalyzed C-H activation route to isoxazolidines, offering mild conditions and broad substrate scope for reliable pharmaceutical intermediate supply.
Novel isoindolinone-derived unsaturated imine synthesis via binaphthyl phosphoric acid. Delivers high yield, scalable production, and cost advantages for pharmaceutical supply chains.
Patent CN113135840A reveals a metal-free fluoride-catalyzed route for conjugated alkenyl amidines, offering significant cost reduction in API manufacturing and scalable production.
Patent CN105152946B reveals ionic liquid catalysis for o-aminobenzaldehyde. High yield, mild conditions, supply chain stability. Ideal for pharmaceutical intermediate manufacturing.
Patent CN116640146A reveals efficient Pd-catalyzed synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN104529895B reveals a one-step aqueous synthesis for isoquinoline derivatives. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel palladium catalyzed route avoids toxic CO gas. Enhances supply chain safety and reduces operational complexity for pharmaceutical intermediate manufacturing.
Patent CN119751313B enables efficient synthesis. Reduces cost and lead time for high-purity pharmaceutical intermediates via novel SuFEx chemistry.